Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report

ABSTRACT A 34‐year‐old Ghanaian male with no past medical history presented to our hospital with dyspnoea, left‐sided chest pain, and left‐eye visual disturbance. Imaging revealed a large mediastinal mass with vascular invasion, left pleural and skeletal metastases. A lung biopsy confirmed lung aden...

Full description

Saved in:
Bibliographic Details
Main Authors: Bassem Alhariri, Arwa Elfatih, Osman Osama Elhassan, Mohamed Elfatih, Aya Mohamed Kheir, Razan Elkhatib
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Respirology Case Reports
Subjects:
Online Access:https://doi.org/10.1002/rcr2.70170
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839650858880466944
author Bassem Alhariri
Arwa Elfatih
Osman Osama Elhassan
Mohamed Elfatih
Aya Mohamed Kheir
Razan Elkhatib
author_facet Bassem Alhariri
Arwa Elfatih
Osman Osama Elhassan
Mohamed Elfatih
Aya Mohamed Kheir
Razan Elkhatib
author_sort Bassem Alhariri
collection DOAJ
description ABSTRACT A 34‐year‐old Ghanaian male with no past medical history presented to our hospital with dyspnoea, left‐sided chest pain, and left‐eye visual disturbance. Imaging revealed a large mediastinal mass with vascular invasion, left pleural and skeletal metastases. A lung biopsy confirmed lung adenocarcinoma (LUAD) with mixed solid and lepidic growth patterns, showing 80% PD‐L1 expression. Positron emission tomography (PET) identified a highly active lesion in the left eye, suggestive of retinal metastasis. Ophthalmologic evaluation confirmed retinal involvement. Given ROS1 positivity, Crizotinib was initially prescribed but switched to Lorlatinib due to concerns regarding retinal involvement. The patient demonstrated rapid clinical improvement, including notable visual recovery, with stable performance status after 1 month. This case underscores LUAD's potential for atypical metastasis, such as to the retina, necessitating comprehensive assessment and personalised management strategies. The shift from Crizotinib to Lorlatinib highlights the importance of targeted therapy in managing advanced NSCLC with rare metastatic involvement.
format Article
id doaj-art-0a84c12c57a8488a872d3e7c4ce8c4cc
institution Matheson Library
issn 2051-3380
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Respirology Case Reports
spelling doaj-art-0a84c12c57a8488a872d3e7c4ce8c4cc2025-06-26T15:52:48ZengWileyRespirology Case Reports2051-33802025-06-01136n/an/a10.1002/rcr2.70170Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case ReportBassem Alhariri0Arwa Elfatih1Osman Osama Elhassan2Mohamed Elfatih3Aya Mohamed Kheir4Razan Elkhatib5Department of Medicine Hamad Medical Corporation Doha QatarMedical Education Department Hamad Medical Corporation Doha QatarMedical Education Department Hamad Medical Corporation Doha QatarMedical Education Department Hamad Medical Corporation Doha QatarMedical Education Department Hamad Medical Corporation Doha QatarMedical Education Department Hamad Medical Corporation Doha QatarABSTRACT A 34‐year‐old Ghanaian male with no past medical history presented to our hospital with dyspnoea, left‐sided chest pain, and left‐eye visual disturbance. Imaging revealed a large mediastinal mass with vascular invasion, left pleural and skeletal metastases. A lung biopsy confirmed lung adenocarcinoma (LUAD) with mixed solid and lepidic growth patterns, showing 80% PD‐L1 expression. Positron emission tomography (PET) identified a highly active lesion in the left eye, suggestive of retinal metastasis. Ophthalmologic evaluation confirmed retinal involvement. Given ROS1 positivity, Crizotinib was initially prescribed but switched to Lorlatinib due to concerns regarding retinal involvement. The patient demonstrated rapid clinical improvement, including notable visual recovery, with stable performance status after 1 month. This case underscores LUAD's potential for atypical metastasis, such as to the retina, necessitating comprehensive assessment and personalised management strategies. The shift from Crizotinib to Lorlatinib highlights the importance of targeted therapy in managing advanced NSCLC with rare metastatic involvement.https://doi.org/10.1002/rcr2.70170lung adenocarcinomanon‐small cell lung cancerretinal metastasistargeted therapyvascular invasion
spellingShingle Bassem Alhariri
Arwa Elfatih
Osman Osama Elhassan
Mohamed Elfatih
Aya Mohamed Kheir
Razan Elkhatib
Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
Respirology Case Reports
lung adenocarcinoma
non‐small cell lung cancer
retinal metastasis
targeted therapy
vascular invasion
title Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
title_full Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
title_fullStr Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
title_full_unstemmed Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
title_short Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report
title_sort lung adenocarcinoma with extensive vascular invasion and retinal metastasis a case report
topic lung adenocarcinoma
non‐small cell lung cancer
retinal metastasis
targeted therapy
vascular invasion
url https://doi.org/10.1002/rcr2.70170
work_keys_str_mv AT bassemalhariri lungadenocarcinomawithextensivevascularinvasionandretinalmetastasisacasereport
AT arwaelfatih lungadenocarcinomawithextensivevascularinvasionandretinalmetastasisacasereport
AT osmanosamaelhassan lungadenocarcinomawithextensivevascularinvasionandretinalmetastasisacasereport
AT mohamedelfatih lungadenocarcinomawithextensivevascularinvasionandretinalmetastasisacasereport
AT ayamohamedkheir lungadenocarcinomawithextensivevascularinvasionandretinalmetastasisacasereport
AT razanelkhatib lungadenocarcinomawithextensivevascularinvasionandretinalmetastasisacasereport